8-K: LENSAR Stockholders Re-Elect Directors, Ratify Auditor

LENSAR, Inc. announced the results of its annual meeting, where stockholders re-elected three Class II directors and ratified PricewaterhouseCoopers LLP as its independent auditor.

Summary

• LENSAR, Inc. held its annual meeting of stockholders on December 18, 2025.
• As of the record date, October 24, 2025, there were 11,944,546 shares of common stock and 20,000 shares of Series A Convertible Preferred Stock issued and outstanding.
• Total voting power was 19,884,992 votes, with 17,513,871 votes, representing approximately 88.07% of the total voting power, present or represented by proxy at the meeting.
• Nicholas T. Curtis, Todd B. Hammer, and Aimee S. Weisner were re-elected as Class II directors to serve until the company's annual meeting of stockholders in 2028.
• The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified by stockholders.

Sentiment

Score: 7

Explanation: The filing reports successful and routine corporate governance actions, including the re-election of directors and ratification of the auditor, indicating stable operations and shareholder alignment on these matters.

Positives

• Stockholders successfully re-elected all three Class II directors, ensuring continuity in board leadership.
• The appointment of PricewaterhouseCoopers LLP as the independent auditor was ratified with overwhelming support, receiving 17,469,668 votes FOR.
• High stockholder participation was observed, with 88.07% of total voting power represented at the meeting.

Future Outlook

The re-elected Class II directors are set to serve until the company's annual meeting of stockholders in 2028, providing board continuity for the next three years.

Management Comments

• The report was signed by Nicholas T. Curtis, Chief Executive Officer, indicating management's official acknowledgment of the voting results.

Industry Context

This filing represents a routine corporate governance event for a publicly traded company, reflecting standard practices for annual stockholder meetings and board elections within the medical technology or ophthalmic device industry.

Corporate Governance

Stakeholder Impact

• Shareholders: Exercised their voting rights on key governance matters, including director elections and auditor ratification, demonstrating their oversight and participation in company affairs.
• Board of Directors: Achieved continuity of leadership with the re-election of Class II directors.
• Management: The CEO signed the report, indicating official acknowledgment of the results.

Next Steps

• The re-elected Class II directors will serve until the 2028 annual meeting of stockholders.
• PricewaterhouseCoopers LLP will serve as the independent auditor for the fiscal year ending December 31, 2025.

Key Dates

Keywords

LENSAR, LNSR, Annual Meeting, Stockholders, Director Election, Auditor Ratification, Corporate Governance, SEC Filing, 8-K